BioSpace News Archive

Collaboration with Cellex Cell Professionals to Support International Standardization of the Cell Therapy Industry

Medicare Shared Savings Program Net Savings Reached $541.7 Million for 2013-2015 After Accounting for Shared Savings Earned by ACOs

Company Plans to Submit Supplemental New Drug Applications in the US and EU

Akero’s lead program AKR-001 to advance into Phase 2 clinical studies in 2019

Research by Milken Institute and Depression and Bipolar Support Alliance is designed to yield patient input to guide research and treatment; Early results suggest pre-adolescent treatment may be needed

Casma Therapeutics, Inc. today announced a research collaboration with Fondazione Telethon, founder of the Telethon Institute of Genetics and Medicine (TIGEM), to develop new therapies for lysosomal storage disorders and more common disorders such as neurodegeneration.

PolarityTE, Inc. (Nasdaq: COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences, today announced that it was awarded best podium presentation at the 2018 American Professional Wound Care Association (APWCA)

OrthoBethesda, a premier provider of orthopedic services in the greater Washington, DC region, has partnered with Atlantic Street Capital to create a dynamic orthopedic practice

Incyte Corporation (NASDAQ:INCY) and Foundation Medicine, Inc., today announced that the companies have entered into an agreement for the development, regulatory support and commercialization of companion diagnostics (CDx), with an initial focus on CDx development for pemigatinib (INCB54828), Incyte’s selective FGFR1/2/3 inhibitor, in patients with cholangiocarcinoma.

Bio2 Technologies, Inc., a privately held orthopedics company, announced today the closing of its Series C equity financing led by DSM Venturing